Healthcare -
Biotechnology - NASDAQ - US
$ 3.65
-12.7 %
$ 126 M
Market Cap
-3.88
P/E
GNLX - STOCK-BASED COMPENSATION
Stock-based Compensation GNLX - Genelux Corporation
5.2 M
LAST VALUE
10.38%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR